CAZZANIGA MARINA ELENA

Ruolo:

Ricercatore a tempo determinato

Settore scientifico disciplinare:

ONCOLOGIA MEDICA (MED/06)

Afferenza:

E-mail:

Pizzuti, L., Krasniqi, E., Barchiesi, G., Della Giulia, M., Izzo, F., Sanguineti, G., et al. (2020). Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. INTERNATIONAL JOURNAL OF CANCER, 146(7), 1917-1929. Dettaglio
Krasniqi, E., Pizzuti, L., Barchiesi, G., Sergi, D., Carpano, S., Botti, C., et al. (2020). Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence. JOURNAL OF CELLULAR PHYSIOLOGY. Dettaglio
Jacobs, S., Robidoux, A., Abraham, J., Pérez-Garcia, J., La Verde, N., Orcutt, J., et al. (2020). Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer. BREAST CANCER RESEARCH, 22(1). Dettaglio
Alberti, P., Cicchiello, F., Riva, F., & Cazzaniga, M. (2020). Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study.. In MEETING PROCEEDINGS.. Dettaglio
Caruso, A., Caccuri, F., Bugatti, A., Zani, A., Vanoni, M., Bonfanti, P., et al. (2020). Methotrexate inhibits SARS-CoV-2 virus replication "in vitro". JOURNAL OF MEDICAL VIROLOGY. Dettaglio

Futuri studenti - Iscrizioni